The's trading volume drops 37.73% to 10.09 billion, ranks 53rd as Hims & Hers Health Inc reports 111% revenue surge
Generated by AI AgentAinvest Market Brief
Monday, May 5, 2025 8:00 pm ET1min read
HIMS--
On May 5, 2025, The's trading volume was 10.09 billion, a decrease of 37.73% compared to the previous day, ranking 53rd in the day's stock market.
Hims & Hers Health, Inc. reported its financial results for the first quarter of 2025, with revenue reaching 586 million, a year-over-year increase of 111%. The net profit was 49.5 million, and the adjusted EBITDA was 91.1 million. This financial performance is a significant indicator of the company's growth and profitability, which could positively influence investor confidence and potentially impact The's stock price.

Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet